生物型长柄人工股骨头置换术治疗股骨粗隆间骨折的临床疗效分析

Analysis of clinical efficacy of biological long handle artificial femoral head replacement in the treatment of femoral intertrochanteric fracture

目的探讨生物型长柄人工股骨头置换术(FHR)治疗股骨粗隆间骨折的临床疗效。方法回顾性分析105例股骨粗隆间骨折患者的病历资料,依据手术方式不同分为对照组(52例)和研究组(53例)。对照组实施股骨近端抗旋髓内钉(PFNA)治疗,研究组实施生物型长柄人工股骨头置换术治疗。比较两组患者手术时间、术中出血量以及手术前后的Harris评分。结果研究组患者手术时间(81.2±9.6)min长于对照组的(66.5±6.8)min,差异具有统计学意义(P<0.05);研究组患者术中出血量(314.5±24.7)ml与对照组的(324.2±25.6)ml比较,差异无统计学意义(P>0.05)。术后,两组患者Harris评分均较本组术前升高,且研究组患者Harris评分(91.2±4.2)分高于对照组的(83.5±4.4)分,差异具有统计学意义(P<0.05)。结论尽管生物型长柄人工股骨头置换术治疗股骨粗隆间骨折手术时间长,但患者术中出血量未增加,且术后髋关节功能恢复效果优于PFNA方式,值得临床推广应用。

Objective To discuss the clinical efficacy of biological long handle artificial femoral head replacement(FHR)in the treatment of femoral intertrochanteric fracture.Methods The medical records of 105 patients with femoral intertrochanteric fracture were retrospectively analyzed and divided into a control group(52 cases)and a study group(53 cases)according to different surgical methods.The control group was treated with proximal femoral nail anti-rotation(PFNA),and the study group was treated with biological long handle artificial femoral head replacement.The operative time,intraoperative blood loss and Harris score before and after surgery were compared between the two groups.Results The operative time of(81.2±9.6)min in the study group was longer than that of(66.5±6.8)min in the control group,and the difference was statistically significant(P<0.05).There was no statistically significant difference in intraoperative blood loss between the study group(324.2±25.6)ml and the control group(314.5±24.7)ml(P>0.05).After surgery,the Harris score in both groups was higher than that before surgery in this group,and the Harris score of(91.2±4.2)points in the study group was higher than that of(83.5±4.4)points in the control group.The differences were statistically significant(P<0.05).Conclusion Although the operative time of biological long handle artificial femoral head replacement in the treatment of femoral intertrochanteric fracture is long,the intraoperative blood loss does not increase,and the postoperative hip function recovery is better than PFNA,which is worthy of clinical promotion.